Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.47 |
| ▸ | PTGS1 known ✓ | P23219 | 3/20 | 0.42 |
| ▸ | PTGS2 known ✓ | P35354 | 3/20 | 0.42 |
| ▸ | CXCR1 known ✓ | P25024 | 2/20 | 0.42 |
| ▸ | CXCR2 known ✓ | P25025 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL56645 | 0.99 | MEN1 (0.48) | MEN1KMT2ACTSLPTGS1PTGS2 | |
| Water SCHEMBL10824628 | 0.88 | PTGS1 (0.54) | MEN1KMT2APTGS1PTGS2MAPT | |
| Water SCHEMBL11467419 | 0.88 | PTGS1 (0.54) | MEN1KMT2APTGS1PTGS2MAPT | |
| Methane SCHEMBL11468969 | 0.87 | PTGS1 (0.53) | MEN1KMT2APTGS1PTGS2MAPT | |
| SCHEMBL11471719 | 0.87 | PTGS1 (0.55) | MEN1KMT2APTGS1PTGS2MAPT | |
| Water SCHEMBL11470792 | 0.86 | SMN1; SMN2 (0.46) | CTSLPTGS1PTGS2MAPTCXCR1 | |
| Water SCHEMBL11479078 | 0.86 | PTGS1 (0.42) | PTGS1PTGS2MAPTCXCR1CXCR2 | |
| Water SCHEMBL11459151 | 0.85 | PTGS1 (0.54) | MEN1KMT2APTGS1PTGS2MAPT | |
| SCHEMBL11459880 | 0.84 | PTGS1 (0.43) | PTGS1PTGS2MAPTCXCR1CXCR2 | |
| SCHEMBL7531909 | 0.84 | MEN1 (0.57) | MEN1KMT2ACTSLPTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8497304-B2 | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2013-07-30 | — | — | US | claimed |
| US-20120115957-A1 | AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2012-05-10 | — | — | US | claimed |
| EP-1586316-B1 | AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID | SENJU PHARMA CO (JP) | 2008-04-30 | — | — | EP | claimed |
| US-20050239895-A1 | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2005-10-27 | — | — | US | claimed |
| EP-1586316-A1 | AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID | Senju Pharmaceutical Co., Ltd. (JP) | 2005-10-19 | — | — | EP | claimed |
| US-20200360326-A1 | Aqueous Liquid Composition Containing 2-Amino-3-(4-Bromobenzoyl)Phenylacetic Acid | BAUSCH & LOMB INCORPORATED | 2020-11-19 | — | — | US | disclosed |
| EP-2919755-B1 | AQUEOUS LIQUID COMPOSITION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID | BAUSCH & LOMB (US) | 2018-02-21 | — | — | EP | disclosed |
| US-9561277-B2 | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2017-02-07 | — | — | US | disclosed |
| WO-2015170177-A1 | AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2015-11-12 | — | — | WO | disclosed |
| US-9144609-B2 | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2015-09-29 | — | — | US | disclosed |
| EP-2919755-A1 | AQUEOUS LIQUID COMPOSITION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID | Bausch & Lomb Incorporated (US) | 2015-09-23 | — | — | EP | disclosed |
| US-20150025149-A1 | AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2015-01-22 | — | — | US | disclosed |
| US-8497304-B2 | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2013-07-30 | — | — | US | disclosed |
| US-20130090384-A1 | AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2013-04-11 | — | — | US | disclosed |
| US-20120115957-A1 | AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2012-05-10 | — | — | US | disclosed |
| US-8129431-B2 | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2012-03-06 | — | — | US | disclosed |
| EP-1586316-B1 | AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID | SENJU PHARMA CO (JP) | 2008-04-30 | — | — | EP | disclosed |
| US-20070287749-A1 | BROMFENAC OPHTHALMIC FORMULATIONS AND METHODS OF USE | ISTA PHARMACEUTICALS, INC. (US) | 2007-12-13 | — | — | US | disclosed |
| US-20050239895-A1 | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2005-10-27 | — | — | US | disclosed |
| EP-1586316-A1 | AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID | Senju Pharmaceutical Co., Ltd. (JP) | 2005-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130090384-A1 | AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID | PAOX, FFAR2, FFAR3 | MEN1 4831/4885PTGS1 149/4885PTGS2 60/4885 |
| US-20200360326-A1 | Aqueous Liquid Composition Containing 2-Amino-3-(4-Bromobenzoyl)Phenylacetic Acid | AADAT, UACA, IL4 | MEN1 4729/4885PTGS1 549/4885PTGS2 377/4885 |
| US-20150025149-A1 | AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID | PAOX, FFAR2, FFAR3 | MEN1 4831/4885PTGS1 149/4885PTGS2 60/4885 |
| US-20070287749-A1 | BROMFENAC OPHTHALMIC FORMULATIONS AND METHODS OF USE | TRPC3, AADAC, FFAR3 | MEN1 4864/4885PTGS1 199/4885PTGS2 144/4885 |
| US-20120115957-A1 | AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID | PAOX, FFAR2, FFAR3 | MEN1 4831/4885PTGS1 149/4885PTGS2 60/4885 |
| US-20050239895-A1 | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid | PAOX, FFAR2, FFAR3 | MEN1 4831/4885PTGS1 149/4885PTGS2 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.